Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
There are, as of February 6, 2024, a total of 98 HIV care interventions in HRSA's Best Practices Compilation.News Article updated on 02/06/2024
-
Input Sought on Federal HIV Research Priorities
The NIH Office of AIDS Research (OAR) leads the effort across NIH to establish HIV research priorities and develop the NIH Strategic Plan for HIV and HIV-Related Research.News Article updated on 02/15/2024 -
Updated Rule on Confidentiality of Substance Use Disorder Patient Records
HHS has modified rules around confidentiality of substance use disorder patient records, contained in the 42 CFR Part 2 regulations.News Article updated on 02/16/2024 -
Ryan White and World AIDS Day 2023
December 1 is World AIDS Day. The 2023 theme is World AIDS Day 35: Remember and Commit.Blog updated 03/28/2024
-
Southern Interventions: Select Best Practices
Interventions applied in Southern locations, with evidence that they improve HIV care outcomes.Blog updated 08/31/2023
-
Update on Mpox Vaccination Rates
JYNNEOS vaccine coverage remains highly variable across jurisdictions with low uptake of the second dosage, as of November 2023 data.News Article updated on 01/08/2024 -
Clínica Bienestar
Clínica Bienestar (Spanish for “Wellness Clinic”) was developed to provide comprehensive, integrated HIV primary care services to Spanish-speaking and bilingual people of Puerto Rican ancestry, with HIV who inject drugs. Clínica Bienestar is a multilevel, multipronged intervention combining evidence-based practices in behavioral health and HIV medical care with a transnational approach to care. Clínica Bienestar positively impacted retention in HIV medical care and viral suppression.Resource from the RWHAP Best Practices Compilation updated on 05/07/2024
-
Glossary of HIV and Opioid Use Disorder Service Systems Terms
Terms describing key concepts and components of the HIV and opioid use disorder (OUD) care and treatment systems.Resource updated 09/19/2023
-
Best Practices Highlight: New York City Medical Home Model
A New York City HIV medical home model has documented significant improvements in care re-engagement and viral suppression.Blog updated 08/23/2023
-
A Selection of Community Engagement Tools
Access these National Academy of Medicine and RWHAP consumer engagement tools.News Article updated on 06/23/2023 -
A Guide to Support Individuals with HIV/Hepatitis C in Substance Use Service Settings
Guide on how to coordinate HIV/HCV treatment with substance use treatment and recovery.Resource updated 09/19/2023
-
Interrupting Stigma: A Conceptual Map Depicting Stigma Pathways & Intervening Strategies at the Intersection of HIV and Opioid Use Disorder
Tool for addressing stigma in relation to systems-level policies and practices that can improve individual level interventions.Resource updated 09/19/2023
-
Clinical Trial: New Gonorrhea Treatment Effective
A single dose of a novel oral antibiotic called zoliflodacin has been found to be as safe and effective as standard therapy for uncomplicated urogenital gonorrhea in an international Phase 3 non-inferiority clinical trial.News Article updated on 11/16/2023 -
Buprenorphine Curriculum Introduction
Design of curriculum to provide physicians with the information they need to educate their clinic staff and other stakeholders about integrating medication-assisted treatment (MAT) with buprenorphine into HIV primary care.
Curriculum updated on 08/23/2012 -
Module 1: Do We Have a Problem? Examining Opioid Use and HIV
Module to assess provider community's awareness and perspectives on opioid use risks among clients as a decision point on whether to undertake integration of buprenorphine use within the HIV clinic. Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.
Curriculum updated on 08/23/2012 -
Module 2: Key Terms and Definitions
Review of the terminology of addiction, opioid use, and MAT, in order to enhance staff understanding of how buprenorphine treatment fits into the larger treatment picture and improve their health literacy on the subject. Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.
Curriculum updated on 08/23/2012 -
Module 3: What are Opioids? What is MAT?
Overview of addiction and medication-assisted addiction treatment, including buprenorphine and methadone. Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.
Curriculum updated on 08/23/2012 -
Module 4: Which Medications Are Used and How Do They Work?
Review of opioid addiction treatment, specifically buprenorphine, and its variance from methadone and naltrexone opioid addiction treatment options. Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.
Curriculum updated on 08/01/2012 -
Module 5: Key Findings From the SPNS Buprenorphine Initiative
Review of the SPNS Buprenorphine Initiative, the reasons behind its funding, and its overall findings across grantee sites. Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.
Curriculum updated on 08/23/2012 -
Module 6: Prescribing Buprenorphine: How to Get Started
Review of major steps required to get going in buprenorphine certification and administration (e.g., prescribing, administration, staffing). Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.
Curriculum updated on 08/23/2012